 <h1>Tiagabine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to tiagabine: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, tiagabine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking tiagabine:</p><p>
<i>More common</i>
</p><ul>
<li>Blue or purple spots on skin</li>
<li>difficulty in concentrating or paying attention</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Burning, numbness, or tingling sensations</li>
<li> clumsiness or unsteadiness</li>
<li>confusion</li>
<li>itching</li>
<li>mental depression</li>
<li>speech or language problems</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Agitation</li>
<li>bloody or cloudy urine</li>
<li>burning, pain, or difficulty in urinating</li>
<li> frequent urge to urinate</li>
<li>generalized weakness</li>
<li>hostility</li>
<li>memory problems</li>
<li>quick to react or overreact emotionally</li>
<li> rash</li>
<li>uncontrolled back-and-forth and/or rolling eye movements</li>
<li>walking in unusual manner</li>
</ul><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Agitation (severe)</li>
<li>clumsiness or unsteadiness (severe)</li>
<li>coma</li>
<li>confusion (severe)</li>
<li>drowsiness (severe)</li>
<li> increase in seizures</li>
<li>mental depression</li>
<li>severe muscle twitching or jerking</li>
<li> sluggishness</li>
<li>speech problems (severe)</li>
<li>weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of tiagabine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Chills</li>
<li>diarrhea</li>
<li> dizziness</li>
<li>drowsiness</li>
<li> fever</li>
<li>headache</li>
<li>muscle aches or pain</li>
<li>nervousness</li>
<li> sore throat</li>
<li>tremor</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal pain</li>
<li>flushing</li>
<li>impaired vision</li>
<li>increased appetite </li>
<li>increased cough</li>
<li>mouth ulcers</li>
<li>muscle weakness</li>
<li> nausea</li>
<li>pain</li>
<li>trouble in sleeping</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tiagabine: oral tablet</i></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Common (1% to 10%): Rash, pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Dermatitis bullous dermatitis, bruising</p>
<p><b>Frequency not reported</b>: Vesiculobullous rash, exfoliative dermatitis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Vasodilation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (11%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, vomiting, increased appetite, mouth ulceration<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very rare</b> (less than 0.01%): Abnormal hepatic function (elevated SGPT, GGT)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myasthenia, muscle twitching<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infection (15%)</p>
<p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (27%), asthenia (20%), somnolence (18%), nervousness (10%), tremor</p>
<p><b>Common</b> (1% to 10%): Ataxia, paresthesia, abnormal gait, nystagmus, speech disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Nonconvulsive status epilepticus</p>
<p><b>Frequency not reported</b>: Encephalopathy<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Blurred vision, visual field defects</p>
<p><b>Common</b> (1% to 10%): Amblyopia, diplopia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, cough, rhinitis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Difficulty with concentration/attention, insomnia, confusion, memory loss, depressed mood, emotional lability, hostility/aggression, agitation</p>
<p><b>Uncommon</b> (0.1% to 1%): Depression, psychosis</p>
<p><b>Rare</b> (0.01% to 0.1%): Hallucinations, delusion<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Accidental injury (17%)</p>
<p><b>Common</b> (1% to 10%): Pain (unspecified), fatigue<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Tiagabine Hydrochloride (tiaGABine (tiagabine))." Teva Pharmaceuticals USA, North Wales, PA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about tiagabine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>5 Reviews</li>
<li>Drug class: gamma-aminobutyric acid reuptake inhibitors</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tiagabine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Gabitril</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Bipolar Disorder</li>
<li>Epilepsy</li>
<li>Seizures</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tiagabine: oral tablet</i></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Common (1% to 10%): Rash, pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Dermatitis bullous dermatitis, bruising</p><p><b>Frequency not reported</b>: Vesiculobullous rash, exfoliative dermatitis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Vasodilation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (11%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, vomiting, increased appetite, mouth ulceration<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very rare</b> (less than 0.01%): Abnormal hepatic function (elevated SGPT, GGT)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myasthenia, muscle twitching<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infection (15%)</p><p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (27%), asthenia (20%), somnolence (18%), nervousness (10%), tremor</p><p><b>Common</b> (1% to 10%): Ataxia, paresthesia, abnormal gait, nystagmus, speech disorder</p><p><b>Uncommon</b> (0.1% to 1%): Nonconvulsive status epilepticus</p><p><b>Frequency not reported</b>: Encephalopathy<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Blurred vision, visual field defects</p><p><b>Common</b> (1% to 10%): Amblyopia, diplopia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, cough, rhinitis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Difficulty with concentration/attention, insomnia, confusion, memory loss, depressed mood, emotional lability, hostility/aggression, agitation</p><p><b>Uncommon</b> (0.1% to 1%): Depression, psychosis</p><p><b>Rare</b> (0.01% to 0.1%): Hallucinations, delusion<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Accidental injury (17%)</p><p><b>Common</b> (1% to 10%): Pain (unspecified), fatigue<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Tiagabine Hydrochloride (tiaGABine (tiagabine))." Teva Pharmaceuticals USA, North Wales, PA. </p><h2>More about tiagabine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>5 Reviews</li>
<li>Drug class: gamma-aminobutyric acid reuptake inhibitors</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tiagabine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Bipolar Disorder</li>
<li>Epilepsy</li>
<li>Seizures</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>